{
    "2020-10-16": [
        [
            {
                "time": "2023-10-15",
                "original_text": "VENCLEXTAÂ® (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (AML)",
                "features": {
                    "keywords": [
                        "VENCLEXTA",
                        "venetoclax",
                        "FDA",
                        "Full Approval",
                        "Acute Myeloid Leukemia",
                        "AML"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Coronavirus update: Global COVID-19 cases top 38.9 million as trial of promising therapy finds it does not stop patients dying",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "COVID-19",
                        "cases",
                        "therapy",
                        "patients",
                        "dying"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Study finds remdesivir, hydroxychloroquine have 'little' impact on mortality in COVID-19 patients",
                "features": {
                    "keywords": [
                        "remdesivir",
                        "hydroxychloroquine",
                        "mortality",
                        "COVID-19",
                        "patients"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "5 High-Yield Stocks for 5%-Plus Dividend Payouts",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Stocks",
                        "Dividend",
                        "Payouts"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}